| 000 | 01460nam a2200301 a 4500 | ||
|---|---|---|---|
| 001 | EDZ0000072952 | ||
| 003 | StDuBDS | ||
| 005 | 20150804193948.0 | ||
| 006 | m||||||||d|||||||| | ||
| 007 | cr|||||||||||| | ||
| 008 | 071128s2008 enkb fo| 001 0 eng|d | ||
| 020 |
_a9780191723834 (ebook) : _cNo price |
||
| 040 |
_aStDuBDS _cStDuBDS |
||
| 050 | 4 | _aRC607 | |
| 082 | 0 | 4 |
_a616.9792061 _222 |
| 245 | 0 | 2 |
_aA decade of HAART _h[electronic resource] : _bthe development and global impact of highly active antiretroviral therapy / _cedited by Jos�e Zuniga ... [et al.] ; managing editor Lynn-Marie Holland ; [with a foreword by Luc Montagnier and Robert Gallo]. |
| 260 |
_aOxford : _bOxford University Press, _c2008. |
||
| 300 |
_a1 online resource (viii, 516 p.) : _bmaps. |
||
| 520 | 8 | _aHighly active antiretroviral therapy (HAART) is a therapeutic intervention that was developed in order to fight the HIV pandemic. This text reviews the achievements to date, and presents an exploration of the challenges that may arise in the future. | |
| 588 | _aDescription based on print version record. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aHIV infections _xChemotherapy. |
|
| 650 | 0 | _aAntiretroviral agents. | |
| 700 | 1 |
_aZuniga, Jos�e, _d1969- |
|
| 700 | 1 | _aHolland, Lynn-Marie. | |
| 776 | 0 | 8 |
_iPrint version _z9780199225859 |
| 856 | 4 | 0 |
_3Oxford scholarship online _uhttp://dx.doi.org/10.1093/acprof:oso/9780199225859.001.0001 |
| 999 |
_c38572 _d38572 |
||